Uterine (endometrial) cancer is the most common gynecologic cancer in the United States, yet many patients are unfamiliar with the terminology used to describe the disease and how it can vary from person to person. To help break down these concepts, we spoke with Dr. Katherine Fuh, a gynecologic oncologist at UCSF Health. In this […]

Endometrial cancer begins in the lining of the uterus (the endometrium) and is the most common gynecologic cancer in the United States. While many people think of it as a single disease, doctors broadly divide it into two categories: Type 1 and Type 2. These types behave differently, respond to treatment differently, and carry different […]

Every uterine (endometrial) cancer is unique, and understanding the specifics of your tumor can make a big difference in choosing the right treatment. Your care team uses genetic testing and biomarker testing to gather important information about your cancer. These tests can reveal how the tumor behaves, whether it carries inherited gene changes, and which […]

One of the first questions many people have after a uterine (endometrial) cancer diagnosis is, “How advanced is it?” That’s where staging comes in. Staging helps your care team understand how far the cancer has grown, whether it has spread beyond the uterus, and which treatments are likely to be most effective. To figure out […]

Nearly 70,000 people in the United States will be diagnosed with uterine (endometrial) cancer this year. Uterine (endometrial) cancer is the fourth most common cancer in the United States, and while it most often occurs after menopause, it can also affect younger women. Getting this diagnosis can feel all-consuming. Preparing questions in advance can help […]